ATE223715T1 - Verfahren zur behandlung hyperproliferativer epithel-läsionen durch topische verabreichung von hydroxylierten aromatischen protein-crosslinking verbindungen - Google Patents

Verfahren zur behandlung hyperproliferativer epithel-läsionen durch topische verabreichung von hydroxylierten aromatischen protein-crosslinking verbindungen

Info

Publication number
ATE223715T1
ATE223715T1 AT96905555T AT96905555T ATE223715T1 AT E223715 T1 ATE223715 T1 AT E223715T1 AT 96905555 T AT96905555 T AT 96905555T AT 96905555 T AT96905555 T AT 96905555T AT E223715 T1 ATE223715 T1 AT E223715T1
Authority
AT
Austria
Prior art keywords
topical administration
hyperproliferative epithelial
treating hyperproliferative
crosslinking compounds
protein crosslinking
Prior art date
Application number
AT96905555T
Other languages
English (en)
Inventor
Caroline Stanwell
Stuart H Yuspa
Terrence R Burke Jr
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE223715T1 publication Critical patent/ATE223715T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96905555T 1995-02-17 1996-02-14 Verfahren zur behandlung hyperproliferativer epithel-läsionen durch topische verabreichung von hydroxylierten aromatischen protein-crosslinking verbindungen ATE223715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/389,845 US5610185A (en) 1995-02-17 1995-02-17 Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
PCT/US1996/002301 WO1996025159A1 (en) 1995-02-17 1996-02-14 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds

Publications (1)

Publication Number Publication Date
ATE223715T1 true ATE223715T1 (de) 2002-09-15

Family

ID=23539975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905555T ATE223715T1 (de) 1995-02-17 1996-02-14 Verfahren zur behandlung hyperproliferativer epithel-läsionen durch topische verabreichung von hydroxylierten aromatischen protein-crosslinking verbindungen

Country Status (11)

Country Link
US (1) US5610185A (de)
EP (1) EP0809493B1 (de)
JP (1) JPH11503111A (de)
AT (1) ATE223715T1 (de)
AU (1) AU698414B2 (de)
CA (1) CA2212888C (de)
DE (1) DE69623595T2 (de)
DK (1) DK0809493T3 (de)
ES (1) ES2183938T3 (de)
PT (1) PT809493E (de)
WO (1) WO1996025159A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943191B1 (en) 1998-02-27 2005-09-13 The United States Of America As Represented By The Department Of Health And Human Services Disubstituted lavendustin A analogs and pharmaceutical composition comprising the analogs
FR2778560B1 (fr) * 1998-05-12 2001-06-01 Oreal Utilisation de l'acide cinnamique ou d'au moins l'un de ses derives dans une composition destinee a favoriser la desquamation de la peau, et composition le comprenant
GB2370989A (en) * 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
WO2003101927A1 (en) * 2002-05-31 2003-12-11 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US7368593B1 (en) 2003-08-18 2008-05-06 Organics L.L.C. Method of selective esterification
ES2238924B1 (es) 2004-02-17 2006-12-01 Investread Europa, S.L. Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
US20070149618A1 (en) 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
US20080125485A1 (en) 2004-02-17 2008-05-29 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
WO2005092322A1 (ja) * 2004-03-29 2005-10-06 Japan Health Sciences Foundation Ｒａｒ活性化を起こす天然化合物
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
FR2892923B1 (fr) * 2005-11-08 2009-01-16 Engelhard Lyon Sa Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
US8541467B2 (en) 2006-08-16 2013-09-24 Action Medicines, S.L. Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
PT2056815E (pt) 2006-08-16 2013-04-03 Amderma Pharmaceuticals Llc Utilização de derivados de 2,5-dihidroxibenzeno para tratar dermatite
CN117247319A (zh) * 2023-09-08 2023-12-19 中国药科大学 一类5,6-二羟基萘甲酸酯化合物及其制备方法与用途
CN119219499B (zh) * 2024-09-02 2025-09-26 昆明医科大学 倍半萜醇咖啡酸酯类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492815A1 (fr) * 1980-10-23 1982-04-30 Sori Soc Rech Ind Nouveau derive d'acide cinnamoyl-cinnamique, son procede de preparation et son application en therapeutique
US4925877A (en) * 1986-02-25 1990-05-15 Zaidanhojin Biseibutsu Kagaku Kenkyukai Physiologically active erbstatin analogue compounds and compositions
FR2601670B1 (fr) * 1986-07-17 1988-10-07 Cird Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
JPH03109323A (ja) * 1989-09-22 1991-05-09 Microbial Chem Res Found 抗ガン剤
US5360815A (en) * 1993-06-23 1994-11-01 Merck Frosst Canada, Inc. Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis
JPH0761919A (ja) * 1993-08-26 1995-03-07 Kao Corp 美白剤

Also Published As

Publication number Publication date
AU698414B2 (en) 1998-10-29
CA2212888A1 (en) 1996-08-22
DE69623595D1 (de) 2002-10-17
AU4928696A (en) 1996-09-04
DE69623595T2 (de) 2003-05-22
JPH11503111A (ja) 1999-03-23
CA2212888C (en) 2006-10-17
DK0809493T3 (da) 2002-12-23
US5610185A (en) 1997-03-11
EP0809493A1 (de) 1997-12-03
ES2183938T3 (es) 2003-04-01
WO1996025159A1 (en) 1996-08-22
PT809493E (pt) 2003-01-31
EP0809493B1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE223715T1 (de) Verfahren zur behandlung hyperproliferativer epithel-läsionen durch topische verabreichung von hydroxylierten aromatischen protein-crosslinking verbindungen
DE69622265D1 (de) Trizyklische verbindungen zur behandlung von zellproliferativen störungen
DE69528273D1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
MX9707665A (es) Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para el tratamiento de enfermedades proliferativas.
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE69612649D1 (de) Indolinonverbindungen zur behandlung von krankheiten
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
ATE454141T1 (de) Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten
MX9707562A (es) Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para el tratamiento de enfermedades proliferativas.
HU9600957D0 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
MX9707197A (es) Compuestos triciclicos de urea que son utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proliferativas.
MX9304638A (es) Composicion para tratar e inhibir las ulceras gastricas y duodenales.
DE69629184D1 (de) Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus
DE69329559D1 (de) Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen
MX9801093A (es) Inhibidores de la proteinasa c para el tratamiento de enfermedades relacionadas con la sobreproduccion de colagena.
DE10075033I2 (de) substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen.
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
WO1996023489A3 (de) Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
CA2238283A1 (en) Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
DE69617005D1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
ATE213163T1 (de) Verfahren zur behandlung von motorischen defiziten
ATE202935T1 (de) Verfahren zur behandlung von haarausfall

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0809493

Country of ref document: EP

REN Ceased due to non-payment of the annual fee